In this study, we identified eight RS HDRGs (namely, FMO3, ALDH5A1, HSD17B6, APOC4, PON1, ITIH1, A1BG, and ANG) and explored the impact of HDRGs on OS of patients with HCC. Here, FMO3 is linked to hepatocellular carcinoma.